Blood-Based Prognostic Biomarkers in Neuroendocrine Tumour: A Retrospective Study

#1311

Introduction: Markers of systemic inflammation –such as the neutrophil:lymphocyte ratio (NLR), platelet:lymphocyte ratio (PLR) and lymphocyte:monocyte ratio (LMR) - have been shown to correlate with poor prognosis in multiple solid organ tumours. Analysis of CLARINET showed no significant association between NLR and progression-free survival.

Aim(s): To investigate the prognostic value of NLR, PLR and LMR in patients with metastatic NET.

Materials and methods: We identified patients with histologically diagnosed NET, who had a full blood count in the 7 days prior to biopsy or resection. The prognostic impact of NLR – NLR>5 vs NLR<5 (NLR5) and NLR>3 vs NLR<3 (NLR3), PLR (PLR>median vs PLRmedian vs LMR

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Diakos C, Chan D, Gurney E, Bailey D, Barnes T,

Keywords: NLR, biomarker,

To read the full abstract, please log into your ENETS Member account.